Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by SizzlinSteakson May 17, 2018 9:44am

80 Views

Post# 28044643

RE:RE:RE:Theralase Provides Update on Phase Ib Non-Muscle Invasive Bl

There is a 4 month hold on the shares purchased in the PP. They cannot be sold until Sept 15 th... besides even if a private placement holder could sell now it would be foolish.

bionicjoe wrote: We should keep track of the volume to see if any recent contributors to the PP are selling their shares and just holding on to their warrants.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal